ArticlebioRxiv : the preprint server for biology2026
Differential vulnerability of CA1 pyramidal neuron cell types in the 5xFAD Alzheimer's disease mouse model.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Selective neuronal vulnerability is a defining feature of Alzheimer's disease, yet how neurodegeneration unfolds across defined hippocampal CA1 pyramidal neuron populations remains unresolved. Previously, we showed that CA1 pyramidal neurons are organized into molecularly defined laminar cell types that form stable spatial signatures along the longitudinal axis (Pachicano et al., 2025). Here, we investigated how vulnerability manifests across CA1 pyramidal cell types in the 5xFAD mouse model of amyloid pathology. HiPlex single-molecule fluorescence in situ hybridization was used to quantify gene expression at single-cell resolution across hippocampal CA1 subregions across disease progression. Cells were classified into molecularly defined CA1 pyramidal cell types based on marker gene expression, and changes in density, proportion, and molecular state were assessed. Amyloid-associated pathology differentially affected CA1 pyramidal cell types, revealing distinct trajectories of vulnerability and resilience. Specific populations exhibited early and progressive susceptibility, while other populations demonstrated relative preservation across disease timepoints. These effects were consistent across CA1 subregions, indicating that vulnerability follows cell type identity rather than regional anatomy alone. Together, these findings demonstrate that neurodegeneration in Alzheimer's disease is structured by intrinsic cell type identity and provide a cellular framework for understanding selective vulnerability.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.